To improve the efficiency of the therapy of respiratory diseases, the influence of a drug belonging to the group of actoprotectors--bemithyl (bemactor) on the main protector mechanisms of respiratory organs was evaluated, using functional-morphological studies of mucocilliary apparatus and local bronchial immunity. Bemithyl was found to produce no direct influence on these mechanisms, but the use of bemithyl by special technology is perspective for these purposes.